Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

VYLOY

ZOLBETUXIMAB-CLZB

Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VYLOY is listed in Drugs@FDA under application 761365 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLBETUXIMAB-CLZB Form and strength INJECTABLE;INJECTION - 100MG Sponsor ASTELLAS Submission history Latest submission status date: 2025-06-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview VYLOY is listed in Drugs@FDA under application 761365 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLBETUXIMAB-CLZB Form and strength INJECTABLE;INJECTION - 100MG Sponsor ASTELLAS Submission history Latest submission status date: 2025-06-06 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.